Cheshire, United Kingdom

Charles Bell

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Bell. Retrieved from https://idiyas.com/inventor/charles-bell-o9pa5e5n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles Bell

Introduction

Charles Bell is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of chemistry, particularly in the development of new compounds. His work focuses on the creation of heterocyclic compounds that serve as inhibitors for monoacylglycerol lipase.

Latest Patents

Charles Bell holds a patent for "Heterocyclic compounds as monoacylglycerol lipase inhibitors." This invention provides new heterocyclic compounds characterized by a specific general formula. The patent details the compositions that include these compounds, the processes for manufacturing them, and methods for their application.

Career Highlights

Bell is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to explore innovative solutions in drug development and therapeutic applications.

Collaborations

Throughout his career, Charles Bell has collaborated with esteemed colleagues such as Joerg Benz and Luca Claudio Gobbi. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.

Conclusion

Charles Bell's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…